 | Up a level |
2021
Nathan, Paul, Hassel, Jessica C., Rutkowski, Piotr, Baurain, Jean-Francois, Butler, Marcus O., Schlaak, Max, Sullivan, Ryan J., Ochsenreither, Sebastian, Dummer, Reinhard, Kirkwood, John M., Joshua, Anthony M., Sacco, Joseph J., Shoushtari, Alexander N., Orloff, Marlana, Piulats, Josep M., Milhem, Mohammed 
ORCID: 0000-0003-4663-6824, Salama, April K. S., Curti, Brendan, Demidov, Lev, Gastaud, Lauris, Mauch, Cornelia, Yushak, Melinda, Carvajal, Richard D., Hamid, Omid, Abdullah, Shaad E., Holland, Chris, Goodall, Howard and Piperno-Neumann, Sophie
(2021).
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
N. Engl. J. Med., 385 (13).
S. 1196 - 1207.
WALTHAM:
MASSACHUSETTS MEDICAL SOC.
ISSN 1533-4406
2020
Dummer, Reinhard, Sandhu, Shahneen Kaur, Miller, Wilson H., Butler, Marcus O., Blank, Christian U., Munoz-Couselo, Eva, Burris, Howard A., III, Postow, Michael A., Chmielowski, Bartosz, Middleton, Mark R., Berking, Carola, Hassel, Jessica Cecile, Gesierich, Anja, Mauch, Cornelia, Kleha, Joseph, Gollerkeri, Ashwin, Harney, Allison, Pickard, Michael D. and Ascierto, Paolo Antonio (2020). A phase II, multicenter study of encorafenib/binimetinib followed by a rational triple-combination after progression in patients with advanced BRAF V600-mutated melanoma (LOGIC2). J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
2016
Weide, Benjamin, Martens, Alexander, Hassel, Jessica C., Berking, Carola, Postow, Michael A., Bisschop, Kees, Simeone, Ester, Mangana, Johanna, Schilling, Bastian ORCID: 0000-0001-8859-4103, Di Giacomo, Anna Maria, Brenner, Nicole, Kaehler, Katharina, Heinzerling, Lucie, Gutzmer, Ralf, Bender, Armin, Gebhardt, Christoffer ORCID: 0000-0001-7090-9584, Romano, Emanuela, Meier, Friedegund, Martus, Peter, Maio, Michele ORCID: 0000-0002-0323-6321, Blank, Christian, Schadendorf, Dirk, Dummer, Reinhard, Ascierto, Paolo A., Hospers, Geke, Garbe, Claus ORCID: 0000-0001-8530-780X and Wolchok, Jedd D.
(2016).
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.
Clin. Cancer Res., 22 (22).
S. 5487 - 5497.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1557-3265
2015
Mohr, Peter, Hauschild, Axel, Trefzer, Uwe, Enk, Alexander, Tilgen, Wolfgang, Loquai, Carmen, Gogas, Helen, Haalck, Thomas, Koller, Josef, Dummer, Reinhard, Gutzmer, Ralf, Brockmeyer, Norbert, Hoelzle, Erhard, Sunderkoetter, Cord, Mauch, Cornelia, Stein, Annette, Schneider, Lars A., Podda, Maurizio, Goeppner, Daniela, Schadendorf, Dirk and Weichenthal, Michael (2015). Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial. J. Clin. Oncol., 33 (34). S. 4077 - 4087. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755